Affiliation:
1. Department of Pharmacology, Howard University College of Medicine, Washington, DC 20059, USA
2. Faculty of Medicine and Pharmacy of Casablanca, Hassan II University, Casablanca 20100, Morocco
3. Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
Abstract
Autism Spectrum Disorder (ASD), a neurodevelopmental disorder characterized by persistent deficits in social interaction and communication, manifests in early childhood and is followed by restricted and stereotyped behaviors, interests, or activities in adolescence and adulthood (DSM-V). Although genetics and environmental factors have been implicated, the exact causes of ASD have yet to be fully characterized. New evidence suggests that dysbiosis or perturbation in gut microbiota (GM) and exposure to lead (Pb) may play important roles in ASD etiology. Pb is a toxic heavy metal that has been linked to a wide range of negative health outcomes, including anemia, encephalopathy, gastroenteric diseases, and, more importantly, cognitive and behavioral problems inherent to ASD. Pb exposure can disrupt GM, which is essential for maintaining overall health. GM, consisting of trillions of microorganisms, has been shown to play a crucial role in the development of various physiological and psychological functions. GM interacts with the brain in a bidirectional manner referred to as the “Gut–Brain Axis (GBA)”. In this review, following a general overview of ASD and GM, the interaction of Pb with GM in the context of ASD is emphasized. The potential exploitation of this interaction for therapeutic purposes is also touched upon.
Subject
Molecular Biology,Biochemistry
Reference173 articles.
1. Genetic Causes and Modifiers of Autism Spectrum Disorder;Rylaarsdam;Front. Cell. Neurosci.,2019
2. Neuroinflammation in autism spectrum disorders: Exercise as a “pharmacological” tool;Toscano;Neurosci. Biobehav. Rev.,2021
3. Sensory processing in autism: A review of neurophysiologic findings;Marco;Pediatr. Res.,2011
4. Attention-deficit/Hyperactivity Disorder in the context of Autism spectrum disorders;Murray;Curr. Psychiatry Rep.,2010
5. Young, S., Hollingdale, J., Absoud, M., Bolton, P., Branney, P., Colley, W., Craze, E., Dave, M., Deeley, Q., and Farrag, E. (2020). Guidance for identification and treatment of individuals with attention deficit/hyperactivity disorder and autism spectrum disorder based upon expert consensus. BMC Med., 18.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献